Submission Details
| 510(k) Number | K212176 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 12, 2021 |
| Decision Date | December 10, 2021 |
| Days to Decision | 151 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
K212176 is an FDA 510(k) clearance for the CINtec Histology, a Cervical Intraepithelial Neoplasia (cin) Test System (Class II — Special Controls, product code PRB), submitted by Ventana Medical Systems, Inc. (Tucso, US). The FDA issued a Cleared decision on December 10, 2021, 151 days after receiving the submission on July 12, 2021. This device falls under the Pathology review panel. Regulated under 21 CFR 864.1865.
| 510(k) Number | K212176 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 12, 2021 |
| Decision Date | December 10, 2021 |
| Days to Decision | 151 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
| Product Code | PRB — Cervical Intraepithelial Neoplasia (cin) Test System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.1865 |
| Definition | The P16 Cin Test System Is A Qualitative Immunohistochemistry (ihc) Test To Assess The P16ink4a Protein In Formalin-fixed, Paraffin-embedded (ffpe) Cervical Punch Biopsy Tissues. It Is Indicated As An Adjunct To Examination Of Hematoxylin And Eosin (h&e) Stained Slide(s), To Improve Consistency In The Diagnosis Of Cin. Diagnosis Of Cin Presence Or Level Should Be Based On H&e Stained Slide(s) And Other Clinical And Laboratory Test Information. |